PLC
PMVP icon

Peapod Lane Capital’s PMV Pharmaceuticals PMVP Stock Holding History

Peapod Lane Capital’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-202,784
Closed -$284K – 60
2025
Q3 		$284K Sell
202,784
-249,898
-55% -$346K 0.25% 57
2025
Q2 		$480K Sell
452,682
-36,688
-7% -$36K 0.48% 55
2025
Q1 		$533K Buy
489,370
+43,626
+10% +$59.2K 0.6% 52
2024
Q4 		$673K Buy
+445,744
New +$706K 0.67% 51

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Peapod Lane Capital's PMVP Position: Q4 2025 in Review

Peapod Lane Capital sold out of PMV Pharmaceuticals (PMVP) in Q4 2025, closing a stake of 202,784 shares — an estimated $284K sold.

Peapod Lane Capital first reported a position in PMVP in Q4 2024 and held it in 4 quarters. The position peaked at $673K in Q4 2024. 63 funds tracked by Wall St. Rank hold PMVP as of Q4 2025.

  • Peapod Lane Capital reported no remaining PMV Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Peapod Lane Capital sold 202,784 PMV Pharmaceuticals shares in Q4 2025, an estimated $284K.
  • Peapod Lane Capital first reported a position in PMV Pharmaceuticals in Q4 2024 and held it in 4 quarters.
  • Peapod Lane Capital's PMV Pharmaceuticals position peaked at $673K in Q4 2024.
  • 63 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2025.

Based on Peapod Lane Capital's 13F filing for Q4 2025, filed 28 Jan 2026.